Idera Pharmaceuticals (IDRA) Financials

$4.91

$-0.30 (-5.76%)

As on 17-Feb-2023 09:30EDT

Market cap

$27 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	0.05	--	--	1.45	0.66	0.90
Cost of Revenue	2.84	--	--	25.54	26.04	19.41
Gross Profit	-2.79	--	--	-24.09	-25.37	0.90
Operating Expenses	18.73	27.67	36.69	47.33	57.26	67.37
Operating Profit (EBIT)	-23.00	-27.67	-36.69	-46.07	-60.96	-66.47
Other Income	--	--	0.14	1.11	1.09	0.53
Profit before Tax	-22.74	98.09	-112.66	-56.52	-59.88	-65.98
Provision for Tax	-6.04	--	--	--	--	--
Profit after Tax (Net Income)	-16.70	98.09	-112.66	-56.52	-59.88	-65.98
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-16.22	96.94	-112.66	-84.56	-59.88	-65.98

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	20.77	29.45	-91.17	-11.17	63.99	107.70
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	63.68	0.55	126.54	4.14	0.01	0.61
Current Liabilities	19.23	4.86	7.03	54.52	9.02	10.11
Total Liabilities	122.91	34.86	42.40	47.49	73.02	118.42

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	73.61	0.83	1.04	1.22	0.22	1.80
Current Assets	30.07	34.04	41.36	46.27	72.81	116.62
Total Assets	122.91	34.86	42.40	47.49	73.02	118.42
Total Debt*	0.63	0.76	0.95	1.06	--	0.21
Net Current Assets	10.84	29.18	34.33	-8.25	63.79	106.51

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-24.60	-33.77	-44.50	-51.92	-55.26
Cash Flow from Investing Activities	--	4.50	-1.69	-2.40	0.22	28.06
Cash from Financing Activities	--	19.41	28.67	15.49	10.19	59.16
Net Cash Inflow / Outflow	--	--	-6.79	-31.41	-41.51	31.96

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-326.90	224.59	-209.75	-69.67	-62.32
ROE (%)	-71.67	-317.86	220.17	-213.97	-69.76	-62.53
ROA (%)	-19.92	253.91	-250.67	-93.79	-62.56	-56.97
EBIT Margin (%)	-46,093.88	--	--	-3,902.97	-9,043.81	-7,309.76
Net Margin (%)	-34,087.76	--	-82,235.04	-2,205.89	-3,425.69	-4,598.19
Cash Profit Margin (%)	-2.13	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	-1.00	1.19	-0.27	-0.94
EBIT Growth (%)	-188.52	187.08	-99.34	5.60	9.20	-72.11
Net Profit Growth (%)	-168.69	187.07	-99.35	5.62	9.25	-71.88
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.84	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.38	-0.32	0.33	0.74	1.20	1.72
Close Price ($)	6.37	9.69	62.39	30.94	47.09	286.96
High Price ($)	18.02	104.38	93.50	71.23	346.81	390.32
Low Price ($)	5.02	8.63	13.82	24.65	46.75	176.80
Market Cap ($ Cr)	26.50	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	0.03	-0.01	-0.10	--	0.00
Short term debt to equity ratio	0.01	0.01	0.00	-0.01	--	0.00
Current Ratio	1.56	7.00	5.89	0.85	8.07	11.54
Quick Ratio	1.56	--	--	--	--	11.54
Interest Coverage	-144.78	14,014.00	-37,553.00	--	-5,442.73	-1,318.68

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	4,008.16	--	--	--	--	--
Asset Turnover	0.00	--	--	0.02	0.01	0.01
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	11.38	17.31	17.78
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.